BioKorf Overview
- Year Founded
-
2013
- Status
-
Private
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$50K
- Investors
-
3
BioKorf General Information
Description
Developer of prefabricated drug dosages designed to support patient-centric medicine. The company's pharmaceutical dosage forms are customized for physical size, shape, drug release profile, and dose, including fixed and non-fixed combination therapy, enabling healthcare professionals to provide multiple dosage form types into one unique form.
Contact Information
Website
www.biokorf.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Delivery
Other Industries
Drug Discovery
Pharmaceuticals
Primary Office
- 1008 Ravinia Road
- West Lafayette, IN 47906-2327
- United States
+1 (765) 000-0000
BioKorf Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Grant | 31-Jul-2015 | $50K | 0000 | Completed | Generating Revenue | |
| 3. Early Stage VC | 19-May-2015 | 0000 | 0000 | Completed | Generating Revenue | |
| 2. Accelerator/Incubator | 07-Oct-2014 | Completed | Generating Revenue | |||
| 1. Spin-Off | 01-Jan-2013 | Completed | Generating Revenue |
BioKorf Executive Team (3)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Andrew Otte Ph.D | Co-Founder & Chief Executive Officer | ||
| Teresa Carvajal | Co-Founder & Chief Operating Officer | ||
| Rodolfo Pinal | Co-Founder & Chief Scientific Officer |
BioKorf Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| National Science Foundation | Government | 000 0000 | 000000 0 | ||
| Elevate Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Purdue Research Foundation | Limited Partner | Minority | 000 0000 | 000000 0 |